ICICI Prudential Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
ICICI Prudential Asset Management's VRTX Position: Q2 2026 in Review
ICICI Prudential Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 0.29% in Q2 2026, selling an estimated $5.32K and leaving 4,197 shares worth $2.08M. The position accounts for 0.23% of the portfolio, ranked #103.
ICICI Prudential Asset Management first reported a position in VRTX in Q4 2021 and has held it in 19 quarters since. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- ICICI Prudential Asset Management held 4,197 shares of Vertex Pharmaceuticals worth $2.08M as of Q2 2026.
- ICICI Prudential Asset Management sold 12 Vertex Pharmaceuticals shares in Q2 2026, an estimated $5.32K.
- Vertex Pharmaceuticals made up 0.23% of ICICI Prudential Asset Management's portfolio in Q2 2026, its #103 holding.
- ICICI Prudential Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
- 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on ICICI Prudential Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.